

Please try another search
Needham analyst Joseph Stringer maintained a Buy rating on Ionis Pharmaceuticals (NASDAQ:IONS) on Friday, setting a price target of $60, which is approximately 98.15% above the present share price of...
Leerink Partners analyst Mani Foroohar maintained a Hold rating on Ionis Pharmaceuticals (NASDAQ:IONS) on Wednesday, setting a price target of $36, which is approximately 17.76% above the present...
BMO Capital analyst Gary Nachman maintained a Buy rating on Ionis Pharmaceuticals (NASDAQ:IONS) on Wednesday, setting a price target of $66, which is approximately 115.90% above the present share...
Needham analyst Joseph Stringer maintained a Buy rating on Ionis Pharmaceuticals (NASDAQ:IONS) on Tuesday, setting a price target of $60, which is approximately 118.18% above the present share price...
BMO Capital analyst Gary Nachman maintained a Buy rating on Ionis Pharmaceuticals (NASDAQ:IONS) on Friday, setting a price target of $66, which is approximately 152.39% above the present share price...
BMO Capital analyst Gary Nachman maintained a Buy rating on Ionis Pharmaceuticals (NASDAQ:IONS) on Thursday, setting a price target of $66, which is approximately 95.90% above the present share price...
Needham analyst Joseph Stringer reiterated a Buy rating on Ionis Pharmaceuticals (NASDAQ:IONS) on Thursday, setting a price target of $60, which is approximately 77.73% above the present share price...
By Deena Beasley (Reuters) - A late-stage trial of Biogen Inc (NASDAQ:BIIB)'s experimental treatment for an inherited form of amyotrophic lateral sclerosis (ALS) failed to reach its main goal, but...
By Dhirendra Tripathi Investing.com – Biogen (NASDAQ:BIIB) shares rose 4% Thursday following two upgrades as well as new findings showing benefits from a higher dose of a medicine it makes to...
Stock-picker Cathie Wood expects pharmaceutical companies to deliver solid growth in 2021, given the rapid integration of tech and their continuing product innovations. Two top holdings in...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review